<DOC>
<DOCNO>
EP-0010030
</DOCNO>
<TEXT>
<DATE>
19800416
</DATE>
<IPC-CLASSIFICATIONS>
C07C-237/06 A61K-31/165 C07C-231/00 <main>C07C-103/50</main> C07C-237/04 A61P-25/18 C07D-295/15 A61K-31/535 A61K-31/395 C07D-295/14 A61P-21/02 C07C-237/00 C07C-275/00 C07C-231/12 A61K-31/16 A61P-21/00 A61P-25/20 C07C-275/38 C07D-295/00 A61P-25/00 
</IPC-CLASSIFICATIONS>
<TITLE>
derivatives of 2'-(ortho-chloro-benzoyl),4'-chloro-glycin anilide, their preparation and their use in medicines.
</TITLE>
<APPLICANT>
fabre sa pierrefr<sep>pierre fabre s.a.<sep>pierre fabre s.a.125, rue de la faisanderief-75116 parisfr<sep>pierre fabre s.a. <sep>
</APPLICANT>
<INVENTOR>
cousse henri<sep>mouzin gilbert<sep>stenger antoine<sep>cousse, henri<sep>mouzin, gilbert<sep>stenger, antoine<sep>cousse, henrichemin de lastinosf-81000 castresfr<sep>mouzin, gilbert21, rue sainte foyf-81000 castresfr<sep>stenger, antoine11, rue des cigalesf-81000 castresfr<sep>cousse, henri<sep>mouzin, gilbert<sep>stenger, antoine<sep>cousse, henrichemin de lastinosf-81000 castresfr<sep>mouzin, gilbert21, rue sainte foyf-81000 castresfr<sep>stenger, antoine11, rue des cigalesf-81000 castresfr<sep>
</INVENTOR>
<ABSTRACT>
The present invention relates to novel ortho derivatives chloro benzoyl-2 chloro-4 glycylanilide, their preparation and their application as drugs. The compounds of the invention respond to the general formula I in which: R represents a hydrogen atom or an alkyl, R₁ and R₂ group may be identical or different and are selected from hydrogen; Groups: Alcoyle, hydroxyalcoyl, alkenyl and alkynyl optionally substituted one or more times by an alkyl radical; or a Coyle cycloal group of 3 to 6 chainons and possibly substituted with an alkyl radical; provided that, when one of the two symbols R₁ and R₂ represents a hydrogen atom, the other is different from a lower alkyl group or a hydroxyalkyl group; and provided that R₁ and R₂ can not be simultable a lower alkyl group; R₁ and R₂ may further form with the nitrogen atom to which they are connected a nitrogen heterocycle that optionally contains a second hethe ROATOME selected from oxygen and nitrogen. application as anxiolytic agents.
</ABSTRACT>
</TEXT>
</DOC>
